跳至主要内容
临床试验/DRKS00017491
DRKS00017491招募中不适用

Investigation of the BRAF mutation status in the pleural punctate in patients with malignant melanoma, colorectal or lung cancer, that show a BRAF mutation in the primary tumor and the comparison of the result with the conventional cytological / immunohistochemical and molecular cytology findings of the pleural punctate - BCT-BRAF-OzD-2019

Onkologiezentrum Donauwörth0 个研究点目标入组 15 人开始时间: 2019年6月19日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Reliable diagnosis of malignant melanoma, mCRC or NSCLC;
  • Need for a regular therapy-related pleural puncture;
  • BRAF-V600 mutation already detected by NGS procedure in the primary tumor;
  • Signed informed consent form

排除标准

  • Absence of the written consent of the patient

研究者

发起方
Onkologiezentrum Donauwörth

相似试验